Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 800,000 shares at $74.85 ($59.9M) on 2017-08-14, disclosed to the SEC on 2017-08-16.
Open-market sale of $59.9M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.85 | 400,000 | $29.9M | 50.0% |
| 2 | $74.85 | 400,000 | $29.9M | 50.0% |
| Total | $74.85 avg | 800,000 | $59.9M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |